For the 8,000 to 10,000 people and their families in and around Tucson who are living with Parkinson’s disease — and the many people who are undiagnosed — this walk is for you. “We want to bring the ...
Introduction Accumulating evidence suggests that glucagon-like peptide-1 (GLP-1) receptor agonists may have therapeutic effects against Parkinson’s disease (PD); however, clinical evidence has not yet ...
Objectives This longitudinal study compared emerging plasma biomarkers for neurodegenerative disease between controls, patients with Alzheimer’s disease (AD), Lewy body dementia (LBD), frontotemporal ...
Abstract: Striatum segmentation on dopamine transporter (DaT) SPECT is necessary to quantify striatal uptake for Parkinson’s disease (PD), but is challenging due to the inferior resolution. This work ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...